Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Traits-guided, Adaptive, Bayesian Basket Trial

All-cause mortality,Number of patients with persistent life-supportive therapies

PALETTE is a perpetual adaptive platform to efficiently study sepsis interventions within
 'treatable traits' in all-ages patients enabling prompt evaluation of pandemic treatments.
 Treatable traits, therapeutic targets identified by phenotypes or endotypes (defined by
 biological mechanism or by treatment response) through validated biomarkers (measurable
 characteristic reflecting normal or pathogenic processes, or treatment responses), may
 include multi-omics, cellular, immune, metabolic, endocrine features, or intelligent
 algorithms. PALETTE Bayesian adaptive design enables parallel investigations of multiple
 interventions for sepsis, and quick inclusion of pandemic pathogens. PALETTE's new conceptual
 model will respond to the challenges of standard approaches, i.e. series of sepsis trials,
 each investigating one or two interventions, expensive, time consuming, and inappropriate in
 pandemic context.